Cleared Traditional

K860733 - CK-NAC REAGENT CREATINE KINASE N-ACETYL...

K860733 is the FDA 510(k) clearance for CK-NAC REAGENT CREATINE KINASE N-ACETYL... by Trace Scientific , Ltd.. It is a Class 2 Chemistry device (product code CGS) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K860733 · Trace Scientific , Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1986
Decision
57d
Days
Class 2
Risk

K860733 is an FDA 510(k) clearance for the CK-NAC REAGENT CREATINE KINASE N-ACETYL CYSTEINE. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Trace Scientific , Ltd. (Clayton, Vic 3168, AU). The FDA issued a Cleared decision on April 24, 1986 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Trace Scientific , Ltd. devices

Submission Details

510(k) Number K860733 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 1986
Decision Date April 24, 1986
Days to Decision 57 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 88d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 99
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K860733.
CREATINE PHOSPHOKINASE(CK) PROCEDURE
K863587 · Data Medical Associates, Inc. · Oct 1986
CREATINE PHROSPHOKINASE (CK) PROCEDURE
K861665 · Data Medical Associates, Inc. · Jun 1986
CK REAGENT CARTRIDGE (PRODUCT NO. 88213)
K861879 · Hi Chem, Inc. · May 1986
EMDS CREATINE KINASE ISOENZYME CKMB TEST PACK
K861061 · Em Diagnostic Systems, Inc. · Apr 1986
CREATINE KINASE, N-ACETYL-L-CYSTIENE
K860669 · Em Diagnostic Systems, Inc. · Apr 1986
CPK REAGENT SET (COLORIMETRIC)
K860096 · Sterling Diagnostics, Inc. · Feb 1986